Leader in international health
Marinova is delighted to have been named a finalist in the Australian Export Awards.
The honour comes after Marinova was recently presented with the International Health award at the 31st annual Tasmanian Export Awards. The company will now represent Tasmania in the prestigious national awards program to be held on Wednesday 26 November at Parliament House in Canberra.
The International Health category showcases ‘outstanding success in the fields of health, medical or wellbeing’. It recognises innovative exporters in the fields of biotechnology, biosecurity, medical technology, digital health, e-health, aged care, disability, complementary health, pharmaceuticals and related services.
At the Tasmanian Export Awards, Marinova CEO Paul Garrott highlighted the collective passion of the company's personnel. "As the world leader in fucoidan science, Marinova specialises in the research, development and production of highly bioactive seaweed extracts for the betterment of human health," he said. "Our exceptional team share a genuine drive for manufacturing products of superior quality with exceptional scientific credentials. It is their dedication and expertise that continues to grow Marinova's export success.”
Marinova exports its unique range of bioactive fucoidan extracts to more than 40 countries across the globe. Sustainably sourced and clinically validated, Marinova's extracts are sought after by some of the world's most trusted healthcare brands for inclusion in market-leading nutritional supplements, functional foods and beverages, skincare formulations, and animal health products. The company also supplies high purity fucoidan compounds for global pharmaceutical research.
Pictured above: Marinova CEO Paul Garrott (left) and Deputy Premier of Tasmania Guy Barnett.